SARS-CoV-2 infections in patients enrolled on the Children's Oncology Group standard-risk B-cell acute lymphoblastic leukemia trial, AALL1731

被引:2
作者
Elgarten, Caitlin W. [1 ]
Kairalla, John A. [2 ]
Thompson, Joel C. [3 ]
Miller, Tamara P. [4 ]
Wang, Cindy [2 ]
Conway, Susan [2 ]
Loh, Mignon L. [5 ,6 ]
Raetz, Elizabeth A. [7 ]
Gupta, Sumit [8 ]
Rau, Rachel E. [9 ]
Angiolillo, Anne [10 ]
Rabin, Karen R. [9 ]
Alexander, Sarah [8 ]
机构
[1] Childrens Hosp Philadelphia, Dept Pediat, Div Oncol, Philadelphia, PA USA
[2] Univ Florida, Dept Biostat, Gainesville, FL USA
[3] Univ Missouri Kansas City, Childrens Mercy Hosp, Dept Pediat, Div Hematol Oncol Bone Marrow Transplant, Kansas City, MO USA
[4] Childrens Healthcare Atlanta Egleston, Pediat Hematol Oncol, Atlanta, GA USA
[5] Univ Washington, Seattle Childrens Res Inst, Ben Towne Ctr Childhood Canc Res, Seattle, WA USA
[6] Univ Washington, Seattle Childrens Hosp, Dept Pediat, Seattle, WA USA
[7] NYU Langone, Laura & Isaac Perlmutter Canc Ctr, New York, NY USA
[8] Hosp Sick Children, Div Hematol Oncol, Toronto, ON, Canada
[9] Baylor Coll Med, Pediat Hematol Oncol, Houston, TX USA
[10] Childrens Natl Med Ctr, Ctr Canc & Blood Disorders, Washington, DC USA
来源
EJHAEM | 2023年 / 4卷 / 03期
关键词
B-ALL; pediatrics; SARS-CoV-2; ADOLESCENTS; COVID-19; OUTCOMES; CANCER;
D O I
10.1002/jha2.697
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hematologic malignancy is a risk factor for severe coronavirus disease 2019 (COVID-19) in adults; however, data specific to children with leukemia are limited. High-quality infectious adverse event data from the ongoing Children's Oncology Group (COG) standard-risk B acute lymphoblastic leukemia/lymphoma (ALL/LLy) trial, AALL1731, were analyzed to provide a disease-specific estimate of SARS-CoV-2 infection outcomes in pediatric ALL. Of 253 patients with reported infections, the majority (77.1%) were asymptomatic or mildly symptomatic (CTCAE grade 1/2) and there was a single COVID-19-related death. These data suggest SARS-CoV-2 infection does not confer substantial morbidity among young patients with B-lymphoblastic leukemia/lymphoma (B-ALL/LLy).
引用
收藏
页码:745 / 750
页数:6
相关论文
共 17 条
[1]   COVID-19 in pediatric oncology from French pediatric oncology and hematology centers: High risk of severe forms? [J].
Andre, Nicolas ;
Rouger-Gaudichon, Jeremie ;
Brethon, Benoit ;
Phulpin, Aurelie ;
Thebault, Eric ;
Pertuisel, Sophie ;
Gandemer, Virginie .
PEDIATRIC BLOOD & CANCER, 2020, 67 (07)
[2]   COVID-19 in Children With Cancer in New York City [J].
Boulad, Farid ;
Kamboj, Mini ;
Bouvier, Nancy ;
Mauguen, Audrey ;
Kung, Andrew L. .
JAMA ONCOLOGY, 2020, 6 (09) :1459-1460
[3]   Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group [J].
Elgarten, Caitlin W. ;
Thompson, Joel C. ;
Angiolillo, Anne ;
Chen, Zhiguo ;
Conway, Susan ;
Devidas, Meenakshi ;
Gupta, Sumit ;
Kairalla, John A. ;
McNeer, Jennifer L. ;
O'Brien, Maureen M. ;
Rabin, Karen R. ;
Rau, Rachel E. ;
Rheingold, Susan R. ;
Wang, Cindy ;
Wood, Charlotte ;
Raetz, Elizabeth A. ;
Loh, Mignon L. ;
Alexander, Sarah ;
Miller, Tamara P. .
PEDIATRIC BLOOD & CANCER, 2022, 69 (11)
[4]   COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey [J].
Emes, David ;
Huls, Anke ;
Baumer, Nicole ;
Dierssen, Mara ;
Puri, Shiela ;
Russell, Lauren ;
Sherman, Stephanie L. ;
Strydom, Andre ;
Bargagna, Stefania ;
Brandao, Ana Claudia ;
Costa, Alberto C. S. ;
Feany, Patrick T. ;
Chicoine, Brian Allen ;
Ghosh, Sujay ;
Rebillat, Anne-Sophie ;
Sgandurra, Giuseppina ;
Valentini, Diletta ;
Rohrer, Tilman R. ;
Levin, Johannes ;
Lakhanpaul, Monica .
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
[5]   Assessment of enrollment characteristics for Children's Oncology Group (COG) upfront therapeutic clinical trials 2004-2015 [J].
Faulk, Kelly E. ;
Anderson-Mellies, Amy ;
Cockburn, Myles ;
Green, Adam L. .
PLOS ONE, 2020, 15 (04)
[6]   COVID-19 in persons with haematological cancers [J].
He, Wenjuan ;
Chen, Lei ;
Chen, Li ;
Yuan, Guolin ;
Fang, Yun ;
Chen, Wenlan ;
Wu, Di ;
Liang, Bo ;
Lu, Xiaoting ;
Ma, Yanling ;
Li, Lei ;
Wang, Hongxiang ;
Chen, Zhichao ;
Li, Qiubai ;
Gale, Robert Peter .
LEUKEMIA, 2020, 34 (06) :1637-1645
[7]   SARS-CoV-2 in Childhood Cancer in 2020: A Disease of Disparities [J].
Johnston, Emily E. ;
Martinez, Isaac ;
Davis, Elizabeth S. ;
Caudill, Caroline ;
Richman, Joshua ;
Brackett, Julienne ;
Dickens, David S. ;
Kahn, Alissa ;
Schwalm, Carla ;
Sharma, Archana ;
Patel, Pratik A. ;
Bhatia, Smita ;
Levine, Jennifer M. ;
Wolfson, Julie A. .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (34) :3778-+
[8]  
Loh M., 2021, COVID-19 and pediatric ALL: frequently asked questions
[9]   Characterization of COVID-19 disease in pediatric oncology patients: The New York-New Jersey regional experience [J].
Madhusoodhan, P. Pallavi ;
Pierro, Joanna ;
Musante, Jordan ;
Kothari, Prachi ;
Gampel, Bradley ;
Appel, Burton ;
Levy, Adam ;
Tal, Adit ;
Hogan, Laura ;
Sharma, Archana ;
Feinberg, Shari ;
Kahn, Alissa ;
Pinchinat, Ashley ;
Bhatla, Teena ;
Glasser, Chana L. ;
Satwani, Prakash ;
Raetz, Elizabeth A. ;
Onel, Kenan ;
Carroll, William L. .
PEDIATRIC BLOOD & CANCER, 2021, 68 (03)
[10]   Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study [J].
Mukkada, Sheena ;
Bhakta, Nickhill ;
Chantada, Guillermo L. ;
Chen, Yichen ;
Vedaraju, Yuvanesh ;
Faughnan, Lane ;
Homsi, Maysam R. ;
Muniz-Talavera, Hilmarie ;
Ranadive, Radhikesh ;
Metzger, Monika ;
Friedrich, Paola ;
Agulnik, Asya ;
Jeha, Sima ;
Lam, Catherine ;
Dalvi, Rashmi ;
Hessissen, Laila ;
Moreira, Daniel C. ;
Santana, Victor M. ;
Sullivan, Michael ;
Bouffet, Eric ;
Caniza, Miguela A. ;
Devidas, Meenakshi ;
Pritchard-Jones, Kathy ;
Rodriguez-Galindo, Carlos .
LANCET ONCOLOGY, 2021, 22 (10) :1416-1426